Pharma & Biotech

Pliant Therapeutics Inc. concluded its 2025 fiscal year with marked operational improvements, highlighted by a significant reduction in its quarterly...

New clinical findings presented by Anavex Life Sciences have injected optimism into the biopharmaceutical firm's outlook. At a recent specialist...

Johnson & Johnson is currently bolstering its healthcare portfolio with significant operational progress. The company has achieved a key regulatory...

Biotechnology firm Onco-Innovations has successfully closed a private placement, raising the capital required to fund its next stage of clinical...

The Swiss medical technology firm Ypsomed is entering a decisive period, marked by the conclusion of a major capital initiative...

The Danish pharmaceutical giant Novo Nordisk finds itself navigating a complex landscape of regulatory challenges and strategic realignments. Recent developments...

The French biotechnology firm Abivax has issued a firm denial regarding reports of an imminent takeover by pharmaceutical giant AstraZeneca....

The biotechnology firm Asep Medical is moving forward with the development of its diagnostic and anti-biofilm technologies. To reach its...

The therapeutic landscape for chronic inflammatory bowel diseases (IBD) is on the cusp of a significant shift. For years, the...

After a multi-month rally, shares of biotechnology firm ImmunityBio are experiencing a notable correction. Investor sentiment has been dampened by...